WaferGen Biosystems this week named Timothy Triche to its scientific advisory board.
Triche is a professor of pathology and pediatrics at the University of Southern California Keck School of Medicine and director of the Center for Personalized Medicine at Children's Hospital Los Angeles. Until recently, Triche was chief of pathology and laboratory medicine at CHLA for more than 20 years. Prior to that, Triche was section chief and head of molecular diagnostics in the laboratory of pathology at the National Cancer Institute.
Bernd Brust will move from his current position as president of Life Technologies' commercial operations and into the role of president of molecular medicine, Life Tech disclosed in a filing last week with the US Securities and Exchange Commission.
Brust will be replaced as president of commercial operations at the beginning of the coming year by Nicolas Barthelemy, who has been leading the firm's Cell Systems division.
Life Technologies said that the Molecular Medicine business unit was formed to enable it to develop new strategies related to transitioning next-generation sequencing activities into clinical uses.